Delivery Order SPE2DB20D1047-SPE2DB25FF49T
Award Date 3/18/25
Potential Completion Date 3/19/25
Potential Value $8.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,122.54 firm fixed-price contract is for the supply of IBSRELA 50 MG TABLET UU 60S medical products. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication IBSRELA 50 MG TABLET UU 60S. The contract has a firm fixed price of $19,570.07 and a period of performance through May 22, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has a firm fixed price of $3,425.94 and a period of performance through May 15, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,251.02, is for the procurement of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through July 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product, with a firm fixed-price ceiling value of $1,180.94 and a period of performance through June 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,475.84 firm-fixed-price delivery order is for the pharmaceutical product "IBSRELA 50 MG TABLET UU 60S" and has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product, with a ceiling value of $2,593.17 and a completion date of November 4, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,944.68, is for the delivery of 60 tablets of the drug IBSRELA 50 MG. The contract has an ultimate completion date of July 3, 2023 and was awarded on June 30, 2023. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $13,242.25 Delivery Order contract is for the provision of IBSRELA 50 MG TABLET in 60-count units. The contract is a Firm Fixed Price arrangement with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,736.39, is for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The award date is June 4, 2025, with an ultimate completion date of June 5, 2025. This contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp, the prime contractor,...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF49TDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of the drug IBSRELA 50 MG TABLET. The contract has a firm fixed price of $8,109.68 and an ultimate completion date of March 19, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 7/1/25, 9:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 3/18/25 |